Labshake search
Citations for Bio X Cell :
1 - 50 of 171 citations for 6 Fluoro 4 hydroxy 3 nitroquinoline since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2020Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-TIM3 Ab (4 μg/ml, clone RMT-3-23, BioXCell, Lebanon, NH), or 25-hydroxycholesterol (4 μM ...
-
bioRxiv - Immunology 2023Quote: ... injections every 3-4 days with 200 µg irrelevant antibody (clone 2A3, BioXCell), αPD-1 (clone RMP1-14 ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Cancer Biology 2022Quote: ... and anti-mouse PD-1 antibodies (clone RMP1-14, 10 mg/kg, 6 doses, every 3 days) were purchased from BioXcell. All drug treatments were administered intraperitoneally (i.p.).
-
bioRxiv - Immunology 2023Quote: ... or Th17 – rhTGFβ (3 ng mL-1, Miltenyi) + rmIL-6 (20 ng mL-1, Miltenyi) + anti-IFNγ (10 μg mL-1, BioXcell). Cells were then transferred to uncoated tissue culture plates and cultured for an additional 3 days ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2023Quote: NK cells were depleted from C57BL/6 mice starting at 3-4 weeks of age by intraperitoneal injection of 200 µg of anti-NK1.1 mAb (clone PK136, Bio X Cell) every 5 days for 3 weeks.
-
bioRxiv - Cancer Biology 2022Quote: ... anti-mouse IL-6 (BioxCell), recombinant mouse Oncostatin M and IL-6 (Biolegend ...
-
bioRxiv - Immunology 2022Quote: ... 6 μg/mL anti-IL-12 (BioXcell), 10 μg/mL anti-IFNγ (BioXcell ...
-
bioRxiv - Neuroscience 2023Quote: ... anti-mouse IL-6 antibody (BioXCell, BE0046), anti-mouse IL-6 ELISA kit (Sigma ...
-
bioRxiv - Cell Biology 2023Quote: ... mouse anti-6-His (Bio X Cell, AB_2687790) was used for western blot (3 µg/ml) ...
-
bioRxiv - Immunology 2022Quote: ... and anti-IL-6 (MP5-20F3; Bio X Cell) neutralizing Abs ...
-
bioRxiv - Immunology 2020Quote: ... human IgG1 Isotype control mAb (BioXcell, Labanon, NH; n=6), or PBS (n=5) ...
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Immunology 2022Quote: ... Tim-3 was neutralized using InVivoMAb anti-mouse Tim-3 antibodies (10µg/mL) (Bio X Cell, Lebanon, NH) for 1 h prior to rBma-LEC-1 or rBma-LEC-2 treatment.
-
bioRxiv - Immunology 2020Quote: ... or anti-LAG-3 (clone C9B7W, BioXcell) and/or anti-PD-L1 (10F.9G2 ...
-
bioRxiv - Pathology 2021Quote: ... IL-6 neutralizing antibody and IgG control (Bioxcell, BE0046 and BE0088). Rapamycin and Torin1 were purchased from LC Laboratories ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Immunology 2021Quote: ... or anti-TIM-3 (clone RMT3-23, BioXcell), followed by single injections of 100 μg antibody on two consecutive days ...
-
bioRxiv - Immunology 2024Quote: ... and IL-4-reactive monoclonal antibodies for in vivo studies (IL-4 MAb) were purchased from BioXCell (BE0045). All TLR agonists were purchased from Invivogen ...
-
bioRxiv - Immunology 2019Quote: ... anti-IL-4 (BioXcell, 11B11, 10ug/mL), IL-12 (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-4-1BB (clone LOB12.3, BioXCell) treatment ...
-
bioRxiv - Immunology 2022Quote: ... and 3μg/mL anti–IL-4 (BioXcell) were used ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...
-
bioRxiv - Immunology 2023Quote: ... anti-LAG-3 mAb (clone C9B7w, Bio X Cell)9 ...
-
bioRxiv - Immunology 2022Quote: ... Inhibition of CTLA-4 signaling was performed by intraperitoneal injection of 500μg/dose of αCTLA-4 (clone: UC10-4F10-11, BioXcell) supplemented with 1mg/dose of IgG2b isotype (clone ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (10 µg/ml, BioXCell). Th1 cells were then cultured ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone: UC10-4F10-11, BioXcell) or isotype control antibodies (clone ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 Ab (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2022Quote: ... NK cells of C57BL/6 mice were deleted by intraperitoneal injection of anti-NK1.1 (BioXcell) antibodies on day -2 (200 μg/each) ...
-
bioRxiv - Cancer Biology 2022Quote: ... mice were treated with 200 μg anti-mouse IL-6 (MP5-20F3, Bio X Cell) once on alternate days and/or 10 μg anti-mouse G-CSF (67604 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CTLA-4 (BioXCell BE0164), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 200 μg anti-CTLA-4 (clone 9H10, BioXcell), or their respective IgG controls ...
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (clone 11B11, Bio X Cell). Briefly ...
-
bioRxiv - Immunology 2022Quote: ... 15 and αCTLA-4 (9H10; BioXcell; 200 μg/dose) on days 0 ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-4-1BB (clone LOB12.3, Bio X Cell #BP0169), anti-PD-1 (clone 29F.1A12 ...
-
bioRxiv - Cancer Biology 2020Quote: ... mice were treated with anti-IL-6 antibodies (20mg/kg, MP5-20F3 clone, BioXCell, NH, USA) or IgG control antibodies (20mg/kg ...
-
bioRxiv - Immunology 2021Quote: ... and CTLA-4 blocking antibody (clone 9D9, BioXCell, cat. BE0164) were administered either in combination or as single agents at 100ug/antibody/mouse every third day starting on the day of doxycycline diet addition for four total doses.
-
bioRxiv - Microbiology 2020Quote: ... and 25 μg of anti-IL-4 (BioXcell, clone 11B11) were complexed prior to intraperitoneally injection into mice ...
-
bioRxiv - Cancer Biology 2019Quote: ... mice were randomized and treated with αCTLA-4 (BioXCell, BP0164) or isotype control (BioXcell ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Immunology 2021Quote: ... TREG conditions: anti–IL-4 (10 μg/mL, BioXCell, #BE0045), anti-IFN-γ (10 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... and 10 μg/mL a-IL-4 (clone 11B11, BioXCell). For Th17 conditions ...
-
bioRxiv - Immunology 2023Quote: ... Tumor-bearing mice were treated with anti-CTLA-4 (BioXCell) (n=8 ...